Best Penny Stocks Under 10 Cents Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. These penny stocks all have a super-low share price of $0.10 or less and are sorted by average trading volume in dollars. These companies are considered the most actively-traded stocks priced under $0.10. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. NuCana NASDAQ:NCNA$0.03 0.00 (-1.83%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$0.03 0.00 (-5.59%) As of 08/8/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NuCana plc, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat patients with cancer. More about NuCanaMarket Capitalization$200 thousandP/E Ratio0.00Consensus RatingModerate BuyConsensus Price Target$5,000.00 (+15,527,850.3% Upside)Volume167.42 million sharesAverage Volume193.10 million shares Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. Adaptimmune Therapeutics NASDAQ:ADAP$0.08 -0.01 (-6.63%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$0.08 +0.00 (+2.97%) As of 08/8/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom. More about Adaptimmune TherapeuticsMarket Capitalization$20.54 millionP/E Ratio-0.29Consensus RatingHoldConsensus Price Target$1.35 (+1,644.1% Upside)Volume26.02 million sharesAverage Volume50.01 million shares3. Wag! Group NASDAQ:PET$0.05 -0.07 (-58.89%) Closing price 07/29/2025Extended Trading$0.05 0.00 (0.00%) As of 07/29/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Wag! Group Co develops and supports a proprietary marketplace technology platform available as a website and mobile app that enables independent pet caregivers to connect with pet parents. More about Wag! GroupMarket Capitalization$2.44 millionP/E Ratio-0.12Consensus RatingHoldConsensus Price Target$6.00 (+12,374.0% Upside)Volume28.29 million sharesAverage Volume12.53 million shares4. Palatin Technologies NYSEAMERICAN:PTN$0.10 -0.07 (-43.76%) Closing price 05/7/2025Extended Trading$0.10 0.00 (0.00%) As of 05/7/2025 04:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Palatin Technologies, Inc, a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. More about Palatin TechnologiesMarket Capitalization$2.49 millionP/E Ratio-0.06Consensus RatingBuyConsensus Price Target$7.00 (+7,222.2% Upside)Volume14.57 million sharesAverage Volume1.17 million shares5. Nextech3D.AI OTCMKTS:NEXCF$0.08 0.00 (-1.04%) As of 08/8/2025 03:56 PM EasternNextech3D.AI Corporation provides augmented reality technologies, wayfinding technologies, and 3D model services. It focuses on creating 3D WebAR photorealistic models for the prime ecommerce marketplace, as well as other online retailers. More about Nextech3D.AIMarket Capitalization$10.91 millionP/E Ratio-1.27Consensus RatingBuyConsensus Price Target$0.25 (+228.9% Upside)Volume456,911 sharesAverage Volume1.06 million shares6. Crypto OTCMKTS:CRCW$0.0030 +0.00 (+87.50%) As of 08/8/2025 03:59 PM EasternThe Crypto Company does not have significant operations. It was previously involved in the provision of consulting and education services for distributed ledger technologies, for the building of technological infrastructure, and enterprise blockchain technology solutions. More about CryptoConsensus RatingModerate BuyVolume157.24 million sharesAverage Volume14.96 million sharesToday's Range$0.0016▼$0.003250-Day Range$0.0006▼$0.003052-Week Range$0.0005▼$0.00327. MariMed OTCMKTS:MRMD$0.10 +0.00 (+1.04%) As of 08/8/2025 03:51 PM EasternMariMed Inc engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. More about MariMedMarket Capitalization$38.07 millionP/E Ratio-3.25Consensus RatingStrong BuyVolume389,204 sharesAverage Volume453,815 sharesToday's Range$0.09▼$0.108. Ayr Wellness OTCMKTS:AYRWF$0.02 +0.01 (+75.44%) As of 08/8/2025 03:57 PM EasternAyr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. More about Ayr WellnessMarket Capitalization$2.32 millionP/E Ratio-0.01Consensus RatingModerate BuyConsensus Price Target$3.00 (+14,900.0% Upside)Volume2.01 million sharesAverage Volume2.11 million shares9. Ascot Resources OTCMKTS:AOTVF$0.04 0.00 (-3.14%) As of 08/8/2025 03:58 PM EasternAscot Resources Ltd. engages in the exploration, evaluation, and development of mineral properties in the United States and Canada. More about Ascot ResourcesConsensus RatingHoldVolume90,635 sharesAverage Volume615,935 sharesToday's Range$0.04▼$0.0550-Day Range$0.04▼$0.0752-Week Range$0.04▼$0.4610. Vincerx Pharma NASDAQ:VINC$0.04 -0.01 (-18.78%) As of 08/8/2025 03:45 PM EasternVincerx Pharma, Inc, a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. More about Vincerx PharmaMarket Capitalization$208 thousandP/E Ratio0.00Consensus RatingBuyConsensus Price Target$40.00 (+100,402.5% Upside)Volume183,586 sharesAverage Volume603,834 shares11. Exro Technologies OTCMKTS:EXROF$0.06 +0.01 (+9.62%) As of 08/8/2025 03:47 PM EasternExro Technologies Inc focuses on developing generation power-control electronics in Canada. The company offers Exro Coil Driver, which allows the motor to switch between different operational profiles in real-time, as well as have multiple gears for scooters, electric bikes, recreational, light electric cars, motorcycles, fleet vans, electric buses, passenger vehicles, long-haul trucks, and industrial vehicles markets; and Exro Cell Driver, a stationary energy storage system for commercial and industrial energy storage applications. More about Exro TechnologiesMarket Capitalization$32.65 millionP/E Ratio-0.14Consensus RatingReduceVolume252,550 sharesAverage Volume192,868 sharesToday's Range$0.05▼$0.0612. Nikola OTCMKTS:NKLAQ$0.03 0.00 (0.00%) As of 08/8/2025 03:59 PM EasternNikola Corporation operates as a technology innovator and integrator that develops energy and transportation solutions in the United States and internationally. More about NikolaMarket Capitalization$1.52 millionP/E Ratio0.00Consensus RatingHoldConsensus Price Target$6.00 (+23,900.0% Upside)Volume200,300 sharesAverage Volume437,009 shares13. Viracta Therapeutics NASDAQ:VIRX$0.0098 0.00 (0.00%) As of 07/25/2025Viracta Therapeutics, Inc, a clinical-stage precision oncology company, focuses on the treatment and prevention of virus-associated cancers that impact patients worldwide. More about Viracta TherapeuticsMarket Capitalization$389 thousandP/E Ratio-0.01Consensus RatingHoldConsensus Price Target$1.75 (+17,793.7% Upside)Average Volume1.11 million sharesToday's Range$0.0098▼$0.009814. Pinstripes NYSE:PNST$0.06 0.00 (-1.64%) As of 08/8/2025 09:55 AM EasternPinstripes Holdings Inc operates a dining and entertainment concept restaurants. The company provides Italian-American food and beverage menu with bowling, bocce, and event space. More about PinstripesMarket Capitalization$2.41 millionConsensus RatingBuyConsensus Price Target$2.50 (+4,066.7% Upside)Volume38,356 sharesAverage Volume88,219 sharesToday's Range$0.06▼$0.0615. Virpax Pharmaceuticals NASDAQ:VRPX$0.01 0.00 (0.00%) As of 08/8/2025 11:16 AM EasternVirpax Pharmaceuticals, Inc, a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. More about Virpax PharmaceuticalsMarket Capitalization$14 thousandConsensus RatingHoldVolume800 sharesAverage Volume176,953 sharesToday's Range$0.0110▼$0.011050-Day Range$0.01▼$0.4616. SpringBig NASDAQ:SBIG$0.03 -0.01 (-16.97%) As of 08/8/2025 03:07 PM EasternSpringBig Holdings, Inc develops and operates a software platform that provides marketing and customer engagement services to cannabis dispensaries and brands in the United States and Canada. More about SpringBigMarket Capitalization$1.28 millionP/E Ratio-0.34Consensus RatingHoldConsensus Price Target$1.00 (+3,549.6% Upside)Volume148,202 sharesAverage Volume67,983 shares17. Danimer Scientific NYSE:DNMR$0.02 0.00 (0.00%) As of 07/28/2025Danimer Scientific, Inc, a performance polymer company, provides bioplastic replacements for traditional petroleum-based plastics in the United States, Germany, Poland, Belgium, Austria, and internationally. More about Danimer ScientificMarket Capitalization$60 thousandP/E Ratio0.00Consensus RatingReduceConsensus Price Target$4.75 (+23,650.0% Upside)Average Volume48,724 sharesToday's Range$0.02▼$0.0218. Omega Therapeutics OTCMKTS:OMGAQ$0.0030 +0.00 (+50.00%) As of 08/8/2025 10:31 AM EasternOmega Therapeutics, Inc operates as a clinical-stage biotechnology company. The company's OMEGA platform enables control of fundamental epigenetic processes to correct the root cause of disease by restoring aberrant gene expression to a range without altering native nucleic acid sequences. More about Omega TherapeuticsMarket Capitalization$170 thousandP/E Ratio0.00Consensus RatingModerate BuyConsensus Price Target$8.00 (+266,566.7% Upside)Volume23,866 sharesAverage Volume215,590 shares19. Corus Entertainment OTCMKTS:CJREF$0.07 0.00 (0.00%) As of 08/8/2025Corus Entertainment Inc, a media and content company, operates specialty and conventional television networks, and radio stations in Canada and internationally. More about Corus EntertainmentMarket Capitalization$13.46 millionP/E Ratio-0.24Consensus RatingSellAverage Volume8,003 sharesToday's Range$0.07▼$0.0750-Day Range$0.07▼$0.0820. Zapata Computing NASDAQ:ZPTA$0.0020 0.00 (0.00%) As of 08/8/2025 12:43 PM EasternZapata Computing Holdings Inc operates as an industrial generative artificial intelligence (AI) software company in the United States. More about Zapata ComputingMarket Capitalization$77 thousandConsensus RatingBuyConsensus Price Target$1.63 (+81,150.0% Upside)Volume16,275 sharesAverage Volume138,607 sharesToday's Range$0.0020▼$0.018021. Syros Pharmaceuticals NASDAQ:SYRS$0.0011 0.00 (0.00%) As of 08/8/2025 03:53 PM EasternSyros Pharmaceuticals, Inc, a biopharmaceutical company, focuses on the development of treatment for hematologic malignancies. More about Syros PharmaceuticalsMarket Capitalization$1.65 millionP/E Ratio0.00Consensus RatingHoldConsensus Price Target$3.33 (+302,930.3% Upside)Volume13,727 sharesAverage Volume202,595 shares22. Medicine Man Technologies OTCMKTS:SHWZ$0.02 0.00 (0.00%) As of 08/8/2025 09:30 AM EasternMedicine Man Technologies, Inc, doing business as Schwazze, engages in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis related products in Colorado and New Mexico. More about Medicine Man TechnologiesConsensus RatingBuyConsensus Price Target$2.50 (+12,400.0% Upside)Volume6,000 sharesAverage Volume9,293 sharesToday's Range$0.02▼$0.0250-Day Range$0.00▼$0.03 More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 08/04 - 08/08 Rocket Lab Reports Q2 Results: Is the Bull Thesis Still Intact? Airbnb Beats Earnings, But the Growth Story Is Losing Altitude Dutch Bros Just Flipped the Script With a Massive Earnings Beat Amazon Takes an Equity Stake in IonQ—Any Upside Potential? D-Wave Delivers Growth Shock—Investors Eye Quantum Future Is Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity? Constellation Energy’s Earnings Beat Signals a New Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
